A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia-Reference-Cited by-同舟云学术

A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia

Published:2024-06-20 Issue:23 Volume:390 Page:2178-2190
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Chen Yunfei¹^ORCID,Xu Yanmei¹^ORCID,Li Huiyuan¹,Sun Ting¹,Cao Xuan¹,Wang Yuhua¹,Xue Feng¹,Liu Wei¹,Liu Xiaofan¹,Dong Huan¹,Fu Rongfeng¹,Dai Xinyue¹,Wang Wentian¹,Ma Yueshen¹,Song Zhen¹,Chi Ying¹,Ju Mankai¹,Gu Wenjing¹,Pei Xiaolei¹,Yang Renchi¹,Zhang Lei¹

Affiliation:

1. From the National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Chinese Academy of Medical Sciences Key Laboratory of Gene Therapy for Blood Diseases, and the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, and the Tianjin Institutes of Health Science, Tianjin (Y.C., Y.X., H.L., T.S.,...

Funder

Clinical Research Fund of National Center for Clinical Medical Research of Hematology Diseases

National Natural Science Foundation of China

CAMS Innovation Fund for Medical Sciences

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2400409

Reference49 articles.

1. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database

2. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports

3. The Incidence of Idiopathic Thrombocytopenic Purpura in Adults Increases With Age

4. Immune Thrombocytopenia

5. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2025 update on clinical trials in immune thrombocytopenia;American Journal of Hematology;2024-08-06

2. Clinical trial landscape for immune thrombocytopenia: Progress and the long road ahead;European Journal of Internal Medicine;2024-08

3. Long‐term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series;British Journal of Haematology;2024-07-28

4. Bridging Innovation Research with Clinical Application: Clinical Trials at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences;Global Medical Genetics;2024-07-12